| Name | Title | Contact Details |
|---|
We are a leading Scientific Process Organization (SPO), providing scientific knowledge-based services to biopharmaceutical, generic pharmaceutical, consumer product, medical device, contract research and healthcare companies. We partner with our clients through the entire drug development cycle to provide a broad range of services from study design to post marketing surveillance and commercialization support. We deliver consistent quality and compliance across the services by employing scientific rigor in combination with streamlined process, optimal technology and efficient people practices.
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
Intellisphere is a Plainsboro, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Alba Therapeutics Corporation is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Alba Therapeutics Corporation is based in Baltimore, MD. You can find more information on Alba Therapeutics Corporation at www.albatherapeutics.com
Medsphere is leading a revolution in healthcare information technology applications, significantly and positively impacting the way healthcare institutions enhance patient safety, improve clinical efficiency and increase healthcare quality.